Testing biotech Ellume fronts up seeking $500m-plus valuation

SYDNEY: Investors are getting up close and personal with rapid diagnostics company Ellume, ... read more
EQT confirms $2.5bn stake in cancer fighter Icon

BRISBANE: Unlisted cancer treatments network Icon Group has confirmed private equity firm EQT ... read more